Assyro AI

Orange Book product · Brand (NDA)

OMNARIS

CICLESONIDE

Brand (NDA)NDA 022004RX AZURITY

At a glance

Oct 20, 2006

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 20, 2006

    19 yr 11 mo ago

  2. Today

  3. Patent 8371292 expires

    Listed method-of-use patent (U-1356) expiration.

    Feb 01, 2028

    in 1 yr 8 mo

Pharmaceutical detail

Active ingredient

CICLESONIDE

Strength

0.05MG/SPRAY

Dosage form

SPRAY, METERED

Route

NASAL

TE code

Not listed

Application

NDA 022004

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8371292Feb 01, 2028in 1 yr 8 mo
U-1356
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.